IP Library Granted Patent US 12,257,154
Granted Patent B2
US 12,257,154 · App. 18/778,749 · Granted Mar 25, 2025

Total joint replacement infection control devices and methods

Inventors: Brian C. de Beaubien (Dallas, TX); Brian Bowman (Dallas, TX); Benjamin Arnold (Dallas, TX); Erika Lin (Dallas, TX); Kristen Pena (Dallas, TX); Tina John (Dallas, TX)
Assignee: Osteal Therapeutics, Inc.
A61F2/3609A61F2/30907A61F2/34A61F2/36A61F2/38A61F2/40A61F2/4202A61F2002/30387A61F2002/30405A61F2002/30507A61F2002/30517A61F2002/3055A61F2002/30593A61F2002/30672A61F2002/30677A61F2002/3068A61F2002/30784A61F2002/30825A61F2002/30827A61F2002/30878A61F2002/30919A61F2002/3401A61F2002/3613A61F2002/3621A61F2002/3647A61F2002/365A61F2002/368A61F2002/3694A61M2205/04
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,257,154
App. No.
18/778,749
Granted
Mar 25, 2025
Kind
B2
Abstract

An orthopedic system for delivery of a therapeutic agent to a bone includes an elongate stem adapted to be inserted into an intramedullary canal, an inlet configured to receive the therapeutic agent, and one or more outlets configured to deliver the therapeutic agent to the bone. The elongate stem may comprise one or more protrusions to engage the bone, and one or more channels extending longitudinally therein, fluidly coupled to the inlet. The therapeutic agent flows from the inlet through the one or more channels and exits into the intramedullary canal through the one or more outlets. The system may be configured to allow one or more dimensions of the system to be adjusted to accommodate the anatomy of a patient.

Claims (52)

1. A therapeutic fluid delivery system, said system comprising:

a femoral head comprising:

a surface configured to be disposed in an acetabulum of a patient;

a first threaded portion; and

a first plurality of outlets in the surface of the femoral head;

a femoral stem comprising:

a proximal portion comprising a second threaded portion;

a distal portion configured to be disposed in a femoral medullary canal of said patient;

an inlet; and

a second plurality of outlets in the distal portion of the femoral stem, wherein each outlet of the second plurality of outlets is fluidically coupled to the inlet; and

one or more set screws,

wherein the second threaded portion of the proximal portion of the femoral stem is configured to adjustably threadably engage with the first threaded portion of the femoral head in order to both couple the femoral head to the femoral stem and permit adjustment of a distance between the femoral head and the distal portion of the femoral stem, wherein the one or more set screws releasably lock the femoral head and the femoral stem together to maintain the distance in order to form an assembled system, and

further wherein, when a therapeutic fluid is introduced into the assembled system through the inlet, the therapeutic fluid exits both the second plurality of outlets and the first plurality of outlets.

2. The system of claim 1 , wherein said femoral head further comprises at least one recess for accepting the one or more set screws to releasably lock the femoral head relative to the femoral stem.

3. The system of claim 1 , wherein the femoral stem comprises a plurality of protrusions interspersed with a plurality of fluted regions, wherein said plurality of protrusions and said plurality of fluted regions extend axially along a longitudinal axis of the distal portion of the femoral stem, said plurality of protrusions adapted to contact an inner surface of said femoral medullary canal.

4. The system of claim 3 , wherein said second plurality of outlets are positioned within said plurality of fluted regions.

5. The system of claim 3 , wherein said plurality of protrusions comprise a first outermost surface area, wherein said plurality of fluted regions comprise a second outermost surface area, and further wherein the first outermost surface area is 50% or less of the sum of the first outermost surface area and second outermost surface area.

6. The system of claim 1 , wherein, when the femoral stem is implanted in the femoral medullary canal of said patient, 50% or less of a surface area of the distal portion of the femoral stem contacts bone in the femoral medullary canal.

7. The system of claim 1 , wherein the distal portion of the femoral stem is tapered.

8. The system of claim 1 , wherein the therapeutic fluid comprises at least one of saline, an irrigation fluid, and an antibiotic.

9. The system of claim 1 , wherein said therapeutic fluid comprises at least one of vancomycin, tobramycin, or a combination thereof.

10. The system of claim 1 , wherein said femoral head further comprises a first channel internal to said femoral head, wherein each outlet of said first plurality of outlets in said femoral head is fluidically coupled to said first channel;

wherein said femoral stem further comprises a second channel internal to said femoral stem, wherein each outlet of said second plurality of outlets in said femoral stem is fluidically coupled to said second channel, and

further wherein said first channel is fluidically coupled to said second channel in the assembled system.

11. The system of claim 10 , wherein said femoral head further comprises an internal chamber fluidically coupled with said first channel and fluidically coupled with said first plurality of outlets via a plurality of radial channels extending from said internal chamber to said first plurality of outlets, such that fluid that flows into the first channel then passes through said internal chamber and through said plurality of radial channels to said first plurality of outlets.

12. The system of claim 11 , wherein said internal chamber is partially spherically shaped.

13. The system of claim 1 , wherein the femoral head is at least partially hollow.

14. A therapeutic fluid delivery system, said system comprising:

a femoral head comprising:

a first threaded portion; and

a first plurality of outlets in the femoral head;

a femoral stem comprising:

a proximal portion comprising a second threaded portion;

a distal portion configured to be disposed in a femoral medullary canal of said patient;

an inlet; and

a second plurality of outlets in the distal portion of the femoral stem, wherein each outlet of the second plurality of outlets is fluidically coupled to the inlet,

wherein the second threaded portion of the proximal portion of the femoral stem is configured to adjustably threadably engage with the first threaded portion of the femoral head in order to both couple the femoral head to the femoral stem and permit adjustment of a distance between the femoral head and the distal portion of the femoral stem, wherein the femoral head and femoral stem are configured to be releasably locked together to maintain the distance in order to form an assembled system, and

further wherein, when a therapeutic fluid is introduced into the assembled system through the inlet, the therapeutic fluid exits the assembled system from both the second plurality of outlets into the femoral medullary canal and from the first plurality of outlets into said acetabulum, and wherein said therapeutic fluid comprises at least one of vancomycin, tobramycin, or a combination thereof.

15. The system of claim 14 , wherein the system further comprises a locking mechanism for releasably locking the femoral head to the femoral stem.

16. The system of claim 14 , further comprising one or more set screws for releasably locking the femoral head to the femoral stem.

17. The system of claim 14 , wherein said femoral head further comprises at least one recess for accepting a set screw to releasably lock the femoral head relative to the femoral stem.

18. The system of claim 14 , wherein the femoral stem comprises a plurality of protrusions interspersed with a plurality of fluted regions, wherein said plurality of protrusions and said plurality of fluted regions extend axially along a longitudinal axis of the distal portion of the femoral stem, said plurality of protrusions adapted to contact an inner surface of said femoral medullary canal.

19. The system of claim 18 , wherein said second plurality of outlets are positioned within said plurality of fluted regions.

20. The system of claim 18 , wherein said plurality of protrusions comprise a first outermost surface area, wherein said plurality of fluted regions comprise a second outermost surface area, and further wherein the first outermost surface area is 50% or less of the sum of the first outermost surface area and second outermost surface area.

21. The system of claim 14 , wherein, when the femoral stem is implanted in the femoral medullary canal of said patient, 50% or less of a surface area of the distal portion of the femoral stem contacts bone in the femoral medullary canal.

22. The system of claim 14 , wherein the distal portion of the femoral stem is tapered.

23. The system of claim 14 , wherein said femoral head further comprises a first channel internal to said femoral head, wherein each outlet of said first plurality of outlets in said femoral head is fluidically coupled to said first channel;

wherein said femoral stem further comprises a second channel internal to said femoral stem, wherein each outlet of said second plurality of outlets in said femoral stem is fluidically coupled to said second channel, and

further wherein said first channel is fluidically coupled to said second channel in the assembled system.

24. The system of claim 23 , wherein said femoral head further comprises an internal chamber fluidically coupled with said first channel and fluidically coupled with said first plurality of outlets via a plurality of radial channels extending from said internal chamber to said first plurality of outlets, such that fluid that flows into the first channel then passes through said internal chamber and through said plurality of radial channels to said first plurality of outlets.

25. The system of claim 24 , wherein said internal chamber is partially spherically shaped.

26. The system of claim 14 , wherein the femoral head is at least partially hollow.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2024
From: DE BEAUBIEN, BRIAN C.; BOWMAN, BRIAN; ARNOLD, BENJAMIN; LIN, ERIKA; PENA, KRISTEN; JOHN, TINA
To: JOINT PURIFICATION SYSTEMS LLC
Reel/Frame 068243/0889 →
CHANGE OF NAME Recorded Aug 9, 2024
From: JOINT PURIFICATION SYSTEMS LLC
To: JOINT PURIFICATION SYSTEMS, INC.
Reel/Frame 068537/0633 →
CHANGE OF NAME Recorded Aug 9, 2024
From: JOINT PURIFICATION SYSTEMS, INC.
To: OSTEAL THERAPEUTICS, INC.
Reel/Frame 068537/0640 →
Continuity (5)
Continuation 17971080 · Oct 21, 2022
Continuation 16513599 · Jul 16, 2019
Division 14841529 · Aug 31, 2015
Provisional Application 62180986 · Jun 17, 2015
Related Publication 20240366390A1 · Nov 7, 2024
References Cited (216)
US 3648294A · Shahrestani · 1972 [cited by applicant]
US 4274163A · Malcom et al. · 1981 [cited by applicant]
US 4399814A · Pratt, Jr. et al. · 1983 [cited by applicant]
US 4488549A · Lee et al. · 1984 [cited by applicant]
US 4653487A · Maale · 1987 [cited by applicant]
US 4711233A · Brown · 1987 [cited by applicant]
US 4888024A · Powlan · 1989 [cited by applicant]
US 4892550A · Huebsch · 1990 [cited by applicant]
US 5116377A · Skripitz et al. · 1992 [cited by applicant]
US 5133767A · Frey et al. · 1992 [cited by applicant]
US 5133771A · Duncan et al. · 1992 [cited by applicant]
US 5133772A · Hack et al. · 1992 [cited by applicant]
US 5156606A · Chin · 1992 [cited by applicant]
US 5290291A · Linden · 1994 [cited by applicant]
US 5340362A · Carbone · 1994 [cited by applicant]
US 5370698A · Heimke et al. · 1994 [cited by applicant]
US 5376123A · Klaue et al. · 1994 [cited by applicant]
US 5433718A · Brinker · 1995 [cited by applicant]
US 5501687A · Willert et al. · 1996 [cited by applicant]
US 5514137A · Coutts · 1996 [cited by applicant]
US 5549702A · Ries et al. · 1996 [cited by applicant]
US 5554111A · Morrey et al. · 1996 [cited by applicant]
US 5562736A · Ray et al. · 1996 [cited by applicant]
US 5571204A · Nies · 1996 [cited by applicant]
US 5618286A · Brinker · 1997 [cited by applicant]
US 5681289A · Wilcox et al. · 1997 [cited by applicant]
US 5683472A · O'Neil et al. · 1997 [cited by applicant]
US 5693099A · Harle · 1997 [cited by applicant]
US 5702446A · Schenck et al. · 1997 [cited by applicant]
US 5725596A · Burke · 1998 [cited by applicant]
US 5741265A · Chan · 1998 [cited by applicant]
US 5755811A · Tanamal et al. · 1998 [cited by applicant]
US 5827289A · Reiley et al. · 1998 [cited by applicant]
US 5871484A · Spievack et al. · 1999 [cited by applicant]
US 5916269A · Serbousek et al. · 1999 [cited by applicant]
US 5954771A · Richelsoph et al. · 1999 [cited by applicant]
US 5980573A · Shaffner · 1999 [cited by applicant]
US 6066154A · Reiley et al. · 2000 [cited by applicant]
US 6106495A · Scott · 2000 [cited by applicant]
US 6113639A · Ray et al. · 2000 [cited by applicant]
US 6132674A · Compton et al. · 2000 [cited by applicant]
US 6155812A · Smith et al. · 2000 [cited by applicant]
US 6217619B1 · Keller · 2001 [cited by applicant]
US 6235043B1 · Reiley et al. · 2001 [cited by applicant]
US 6248110B1 · Reiley et al. · 2001 [cited by applicant]
US 6336941B1 · Subba Rao et al. · 2002 [cited by applicant]
US 6361731B1 · Smith et al. · 2002 [cited by applicant]
US 6361780B1 · Ley et al. · 2002 [cited by applicant]
US 6423083B2 · Reiley et al. · 2002 [cited by applicant]
US 6447514B1 · Stalcup et al. · 2002 [cited by applicant]
US 6544472B1 · Compton et al. · 2003 [cited by applicant]
US 6589281B2 · Hyde, Jr. · 2003 [cited by applicant]
US 6679890B2 · Margulies et al. · 2004 [cited by applicant]
US 6692529B2 · Shah · 2004 [cited by applicant]
US 6740090B1 · Cragg et al. · 2004 [cited by applicant]
US 6740120B1 · Grimes · 2004 [cited by applicant]
US 6783515B1 · Miller et al. · 2004 [cited by applicant]
US 6899716B2 · Cragg · 2005 [cited by applicant]
US 6921403B2 · Cragg et al. · 2005 [cited by applicant]
US 6942475B2 · Ensign et al. · 2005 [cited by applicant]
US 6942702B2 · Mitsugi et al. · 2005 [cited by applicant]
US 6969404B2 · Ferree · 2005 [cited by applicant]
US 6979336B2 · Durniak · 2005 [cited by applicant]
US 6981981B2 · Reiley et al. · 2006 [cited by applicant]
US 6989033B1 · Schmidt · 2006 [cited by applicant]
US 7048743B2 · Miller et al. · 2006 [cited by applicant]
US 7112205B2 · Carrison · 2006 [cited by applicant]
US 7141053B2 · Rosa et al. · 2006 [cited by applicant]
US 7141067B2 · Jones et al. · 2006 [cited by applicant]
US 7211113B2 · Zelener et al. · 2007 [cited by applicant]
US 7217260B2 · Molander et al. · 2007 [cited by applicant]
US 7250055B1 · Vanderwalle · 2007 [cited by applicant]
US 7255713B2 · Malek · 2007 [cited by applicant]
US 7300282B2 · Sapian · 2007 [cited by applicant]
US 7306629B2 · Saladino et al. · 2007 [cited by applicant]
US 7427296B2 · Evans · 2008 [cited by applicant]
US 7429346B2 · Ensign et al. · 2008 [cited by applicant]
US 7534240B1 · Johnson · 2009 [cited by applicant]
US 7572293B2 · Rhodes et al. · 2009 [cited by applicant]
US 7601157B2 · Boyd et al. · 2009 [cited by applicant]
US 7601176B2 · Soffiati et al. · 2009 [cited by applicant]
US 7641698B1 · Gibbs et al. · 2010 [cited by applicant]
US 7771428B2 · Siravo et al. · 2010 [cited by applicant]
US 7842095B2 · Klein · 2010 [cited by applicant]
US 7862619B2 · Clark · 2011 [cited by applicant]
US 7914585B2 · Keller · 2011 [cited by applicant]
US 8038682B2 · McGill et al. · 2011 [cited by applicant]
US 8097039B2 · Evans · 2012 [cited by applicant]
US 8135466B2 · Fuller et al. · 2012 [cited by applicant]
US 8366782B2 · Wright · 2013 [cited by applicant]
US 8388881B2 · Giori · 2013 [cited by applicant]
US 8454706B2 · de Beaubien · 2013 [cited by examiner]
US 8475505B2 · Nebosky et al. · 2013 [cited by applicant]
US 8496711B2 · Anapliotis et al. · 2013 [cited by applicant]
US 8500819B2 · Meridew et al. · 2013 [cited by applicant]
US 8529532B2 · Pinto et al. · 2013 [cited by applicant]
US 8579985B2 · Podolsky et al. · 2013 [cited by applicant]
US 8608802B2 · Bagga et al. · 2013 [cited by applicant]
US 8652216B2 · Chen et al. · 2014 [cited by applicant]
US 8673018B2 · Walls · 2014 [cited by applicant]
US 8685432B2 · Evans et al. · 2014 [cited by applicant]
US 8721520B2 · Caira et al. · 2014 [cited by applicant]
US 8900322B2 · de Beaubien · 2014 [cited by applicant]
US 8900323B2 · de Beaubien · 2014 [cited by applicant]
US 8974538B2 · Teeny et al. · 2015 [cited by applicant]
US 9173742B2 · Faccioli et al. · 2015 [cited by applicant]
US 9198759B2 · Faccioli · 2015 [cited by examiner]
US RE46283E · de Beaubien · 2017 [cited by applicant]
US 9707008B2 · Krebs et al. · 2017 [cited by applicant]
US 9795486B2 · Faccioli et al. · 2017 [cited by applicant]
US RE46669E · de Beaubien · 2018 [cited by applicant]
US 9925363B2 · Magagnoli · 2018 [cited by applicant]
US 10433965B2 · de Beaubien et al. · 2019 [cited by applicant]
US RE48119E · de Beaubien · 2020 [cited by applicant]
US 20010051831A1 · Subba Rao et al. · 2001 [cited by applicant]
US 20020143402A1 · Steinberg · 2002 [cited by applicant]
US 20020169507A1 · Malone · 2002 [cited by applicant]
US 20030060891A1 · Shah · 2003 [cited by applicant]
US 20030097184A1 · Mitsugi et al. · 2003 [cited by applicant]
US 20030187513A1 · Durniak · 2003 [cited by applicant]
US 20040036189A1 · Ensign et al. · 2004 [cited by applicant]
US 20040111162A1 · Southworth · 2004 [cited by applicant]
US 20040193268A1 · Hazebrouck · 2004 [cited by applicant]
US 20040193281A1 · Grimes · 2004 [cited by applicant]
US 20040225360A1 · Malone · 2004 [cited by applicant]
US 20050004680A1 · Saladino et al. · 2005 [cited by applicant]
US 20050021084A1 · Lu et al. · 2005 [cited by applicant]
US 20050107794A1 · Hazebrouck · 2005 [cited by applicant]
US 20050187555A1 · Biedermann et al. · 2005 [cited by applicant]
US 20050277936A1 · Siravo et al. · 2005 [cited by applicant]
US 20060004431A1 · Fuller et al. · 2006 [cited by applicant]
US 20060014120A1 · Sapian · 2006 [cited by applicant]
US 20060030945A1 · Wright · 2006 [cited by applicant]
US 20060093646A1 · Cima et al. · 2006 [cited by applicant]
US 20060121083A1 · Mor · 2006 [cited by applicant]
US 20070005142A1 · Rhodes et al. · 2007 [cited by applicant]
US 20070016163A1 · Santini et al. · 2007 [cited by applicant]
US 20070088442A1 · Cima et al. · 2007 [cited by applicant]
US 20070110804A1 · Royer · 2007 [cited by applicant]
US 20070123835A1 · Molander et al. · 2007 [cited by applicant]
US 20070179609A1 · Goble et al. · 2007 [cited by applicant]
US 20090069899A1 · Klein · 2009 [cited by applicant]
US 20090130167A1 · Shelton et al. · 2009 [cited by applicant]
US 20100042167A1 · Nebosky et al. · 2010 [cited by applicant]
US 20100042213A1 · Nebosky et al. · 2010 [cited by applicant]
US 20100042214A1 · Nebosky et al. · 2010 [cited by applicant]
US 20100042215A1 · Stalcup et al. · 2010 [cited by applicant]
US 20100114324A1 · Gibbs et al. · 2010 [cited by applicant]
US 20100217401A1 · de Beaubien · 2010 [cited by applicant]
US 20100292803A1 · Giori · 2010 [cited by applicant]
US 20110015754A1 · Leonard et al. · 2011 [cited by applicant]
US 20110208315A1 · Anapliotis et al. · 2011 [cited by applicant]
US 20110218644A1 · Meridew et al. · 2011 [cited by applicant]
US 20110236501A1 · Guelcher et al. · 2011 [cited by applicant]
US 20120109303A1 · Capote · 2012 [cited by applicant]
US 20120209382A1 · Forsell · 2012 [cited by applicant]
US 20130041472A1 · Rabiner et al. · 2013 [cited by applicant]
US 20130158595A1 · Mavani et al. · 2013 [cited by applicant]
US 20130209522A1 · Brooks et al. · 2013 [cited by applicant]
US 20130211334A1 · de Beaubien · 2013 [cited by applicant]
US 20130211369A1 · de Beaubien · 2013 [cited by applicant]
US 20130218100A1 · Armbruster et al. · 2013 [cited by applicant]
US 20130237908A1 · Clark · 2013 [cited by applicant]
US 20130289621A1 · Fulmer et al. · 2013 [cited by applicant]
US 20140194810A1 · Barsoum et al. · 2014 [cited by applicant]
US 20140194811A1 · Barsoum et al. · 2014 [cited by applicant]
US 20140277532A1 · Teeny et al. · 2014 [cited by applicant]
US 20150038941A1 · Nebosky · 2015 [cited by examiner]
US 20160199190A1 · Sharifi-Mehr et al. · 2016 [cited by applicant]
US 20200330661A1 · Canner et al. · 2020 [cited by applicant]
US 20200360578A1 · Loske et al. · 2020 [cited by applicant]
CN 104168857A · 2014 [cited by applicant]
DE 3704089A1 · 1988 [cited by applicant]
DE 19722359A1 · 1998 [cited by applicant]
DE 19722389A1 · 1998 [cited by applicant]
DE 102010052914A1 · 2012 [cited by applicant]
EP 0692226A1 · 1996 [cited by applicant]
EP 2326287B1 · 2016 [cited by applicant]
EP 2943164B1 · 2017 [cited by applicant]
GB 2478425A · 2011 [cited by applicant]
IT VI20000025U1 · 2001 [cited by applicant]
JP 2005028129A · 2005 [cited by applicant]
JP 2012500056A · 2012 [cited by applicant]
JP 2012501228A · 2012 [cited by applicant]
JP 2014176714A · 2014 [cited by applicant]
KR 101377900B1 · 2014 [cited by applicant]
NZ 279442A · 1998 [cited by applicant]
WO WO03037166A2 · 2003 [cited by applicant]
WO WO2005122932A2 · 2005 [cited by applicant]
WO WO2007047420A2 · 2007 [cited by applicant]
WO WO2010019781A1 · 2010 [cited by applicant]
WO WO2010080667A1 · 2010 [cited by applicant]
WO WO2012030331A1 · 2012 [cited by applicant]
WO WO2013041906A1 · 2013 [cited by applicant]
WO WO2013059609A1 · 2013 [cited by applicant]
WO WO2014110313A1 · 2014 [cited by applicant]
WO WO2016205077A1 · 2016 [cited by applicant]
Ekpo, T.E. et al. (Sep. 22, 2012). “Abbreviated Two-Stage Exchange Arthroplasty for Periprosthetic Joint Infection: 2 to 6 Year Results.” [Poster presentation]. 31st Annual meeting of the European Bone and Joint Infecti… [cited by applicant]
Finsterbusch, A. et al. (1970). “Bone and joint perfusion with antibiotics in the treatment of experimental staphylococcal infection in rabbits.” J Bone Joint Surg Am, 52(7): p. 1424-1432. [cited by applicant]
Florschutz, A.V. et al. (2015). “Infection after primary anatomic versus primary reverse total shoulder arthroplasty.” J Shoulder Elbow Surg, 24(8): pp. 1296-1301. [cited by applicant]
Lescun, T.B. et al. (2000). “Continuous infusion of gentamicin into the tarsocrural joint of horses.” Am J Vet Res, 61(4): p. 407-412. [cited by applicant]
Lescun, T.B. et al. (2006). “Treatment with continuous intrasynovial antimicrobial infusion for septic synovitis in horses: 31 cases (2000-2003).” J Am Vet Med Assoc, 228(12): p. 1922-1929. [cited by applicant]
Lloyd, K.C. et al. (1988). “Effect of gentamicin sulfate and sodium bicarbonate on the synovium of clinically normal equine antebrachiocarpal joints.” Am J Vet Res, 49(5): p. 650-657. [cited by applicant]
Lloyd, K.C., et al. (1988). “Plasma and synovial fluid concentrations of gentamicin in horses after intra-articular administration of buffered and unbuffered gentamicin.” Am J Vet Res, 49(5): p. 644-649. [cited by applicant]
Schneider, R.K. et al. (1992). “Open drainage, intra-articular and systemic antibiotics in the treatment of septic arthritis/tenosynovitis in horses.” Equine Vet J, 24(6): p. 443-9. [Abstract: 2 pages]. [cited by applicant]
Shelly, M. et al. (2011). “Renal Toxicity Related to Antibiotic-Containing Orthopedic Cement.” Pharmacokinetics and Adverse Drug Reactions. 2 pages. [cited by applicant]
Thabe, H. et al. (2007). “Two-stage Reimplantation with An Application Spacer and Combined with Delivery of Antibiotics in the Management of Prosthetic Joint Infection” Oper. Orthop Traumatol, 1:78-100. [German language… [cited by applicant]
Ure, K.J. et al. (1998). “Direct-exchange arthroplasty for the treatment of infection after total hip replacement. An average ten-year follow-up.” J Bone Joint Surg Am, 80(7): p. 961-968. [cited by applicant]
Whitehair, K.J., et al. (1992). “Regional Limb Perfusion for Antibiotic Treatment of Experimentally Induced Septic Arthritis.” Vet Surg, 21(5): p. 367-73. [Abstract: 2 pages]. [cited by applicant]
Whiteside, L. et al. (2011). “Methicillin-resistant [cited by applicant]
Wroblewski, B.M. (1986). “One-stage Revision of Infected Cemented Total Hip Arthroplasty.” Clin Orthop Relat Res, (211): p. 103-107. [cited by applicant]
Zavala, J.A. et al. (2012). “Management of deep infection after reverse total shoulder arthroplasty: a case series.” J Shoulder Elbow Surg, 21(10): p. 1310-1315. [cited by applicant]
U.S. Appl. No. 17/401,843, filed Aug. 13, 2021, US 2022047392. [cited by applicant]
U.S. Appl. No. 17/971,080, filed Oct. 21, 2022, US 20230041597. [cited by applicant]
PCT/US2024/16687, filed Feb. 21, 2024, WO 2024/178093. [cited by applicant]
PCT/US2024/16660, field Feb. 21, 2021, WO 2024/178070. [cited by applicant]